SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-014108
Filing Date
2013-03-11
Accepted
2013-03-11 06:08:31
Documents
10
Period of Report
2013-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v335258_10q.htm 10-Q 581690
2 CERTIFICATION v335258_ex31-1.htm EX-31.1 9444
3 CERTIFICATION v335258_ex31-2.htm EX-31.2 9838
4 CERTIFICATION v335258_ex32.htm EX-31.2 4816
  Complete submission text file 0001144204-13-014108.txt   4099693

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gnbt-20130131.xml EX-101.INS 405363
6 XBRL TAXONOMY EXTENSION SCHEMA gnbt-20130131.xsd EX-101.SCH 45216
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnbt-20130131_cal.xml EX-101.CAL 54643
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnbt-20130131_def.xml EX-101.DEF 213739
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnbt-20130131_lab.xml EX-101.LAB 363351
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnbt-20130131_pre.xml EX-101.PRE 263125
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 13679146
SIC: 2834 Pharmaceutical Preparations